Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

HEMOSPEC

Financiado

Cerrado

Advanced spectroscopic hemogram for personalized care against live threatening i...

Advanced spectroscopic hemogram for personalized care against live threatening infections using an integrated chip assisted bio photonic system Life threatening infectious diseases and sepsis are worldwide problems with high mortalities. In order to select optimal treatments for the highly heterogeneous group of sepsis patients and to reduce costs, novel multiplexed tools... ver más

31/10/2017

LEIBNIZINSTITUT FU...

5M€

Presupuesto del proyecto: 5M€

Líder del proyecto

LEIBNIZINSTITUT FUER PHOTONISCHE TECHNOLOGIEN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 8 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2017-10-31 No tenemos la información de la convocatoria

0% 75% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

8 Participantes

LEIBNIZINSTITUT FUER PHOTONI...

0.00€ | Lider

CNR

N.D. | Participante

UNIVERSITATSKLINIKUM JENA

N.D. | Participante

UOA

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

RTC-2016-5054-1 VALIDACIÓN EN CONDICIONES REALES DE PRÁCTICA CLÍNICA HABITUA... 668K€ Cerrado

SKIN-CANCER-PROBE A novel handheld probe coupled to mass spectrometer as a non... 145K€ Cerrado

RAIS Scalable point of care and label free microarray platform f... 3M€ Cerrado

ACU-SERS AUTOMATED CLINICAL PLATFORM FOR PERSONALIZED ANTIBIOTHERAPY... 2M€ Cerrado

ADiRaS Alzheimer s Disease Diagnosis by Spectroscopy. Accurate and... 71K€ Cerrado

EQC2019-006148-P Adquisición de un citómetro analizador espectral 110K€ Cerrado

Líder del proyecto

LEIBNIZINSTITUT FUER PHOTONISCHE TECHNOLOGIEN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 5M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Life threatening infectious diseases and sepsis are worldwide problems with high mortalities. In order to select optimal treatments for the highly heterogeneous group of sepsis patients and to reduce costs, novel multiplexed tools that better characterize the patient and its specific immune response are highly desired.In the novel project "HemoSpec" a multidisciplinary team develops - driven by the demands of the two clinical partners - a highly innovative technological platform for early, fast and reliable medical diagnosis of infectious diseases using only minimal amounts of patient's blood. HemoSpec combines in one device three key enabling technologies: automated microfluidic sample handling with integrated holographic blood count, simultaneous multiplex fluorescence biomarker sensing and detailed Raman spectroscopic leukocyte characterization. In each of the technologies experts in the consortium can build on previous knowledge and will improve system characteristics for higher performance and functionality. Strong focus will be on the miniaturization, optimization as well as on the integration of the individual parts. One common user interface, common data storage and analysis software will make the dense information from HemoSpec available to the clinical enduser in a single working step. The integrated multiplex analysis of HemoSpec will be validated in two clinics in two countries specialized on hospital-acquired and community-acquired sepsis, respectively.Strong industrial participation (four companies from four different countries) spanning the portfolio from biomarker supply to spectrometer companies up to software integrators assures ultimate exploitation of the innovative developments and the final device on the market leading to enhanced European market leadership in the field of medical diagnosis. Ultimately, this can help to administer the right therapy to the right patient at the right time reducing the costs in the health care sector.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores